Background: Oxidative stress has repeatedly been linked to the pathogenesis of pulmonary disorders like asthma and chronic obstructive pulmonary disease. Measuring glutathione (GSH) in induced sputum (IS) offers a noninvasive tool to study oxidative stress in airway diseases. Objectives: This study assessed the stability of GSH in sputum supernatant under varying conditions. Methods: GSH in IS of 14 (7 healthy, 4 chronic obstructive pulmonary disease, 3 allergic rhinitis) nonsmoking subjects was quantified spectrophotometrically. The stability of GSH in supernatant was analyzed over 24 h under different ambient conditions (room temperature and cooling at 4°C). Reproducibility of GSH measurements in immediately processed and frozen supernatant (+72 h) was expressed by intraclass correlation coefficient (Ri) and coefficient of repeatability (CR). Results: GSH recovery in supernatant decreased in a time- and temperature-dependent manner. Samples stored at 4°C and room temperature showed a rapid decline of stability after 2 h. Mean GSH concentrations in IS after freezing (–20°C) and thawing after 72 h were not significantly different from GSH values measured immediately after processing of the samples (immediate processing: 17.9 ± 13.9 µM; 72 h freezing: 16.4 ± 12.9 µM, p = 0.2). The reproducibility between immediately processed and frozen samples was excellent (Ri = 0.97; CR = 5.7 µM). Conclusions: Storage of sputum supernatant at room temperature or 4°C leads to a rapid decline of GSH recovery compared with baseline values. Immediate freezing of samples is a suitable and valid alternative to rapid processing and allows collection and shipment of samples for subsequent analysis.

1.
Djukanovic R, Sterk PJ, Fahy JV, Hargreave F: Standardised methodology of sputum induction and processing. Eur Respir J 2002;20:1s–55s.
2.
Davis WB, Pacht ER: Extracellular antioxidant defenses; in Crystal RG, West JB (eds): The Lung. Scientific Foundations. New York, Raven Press, 1991, pp 1821–1828.
3.
MacNee W: Oxidants/antioxidants and chronic obstructive pulmonary disease: Pathogenesis to therapy. Novartis Found Symp 2001;234:169–185.
4.
Dworski R: Oxidant stress in asthma. Thorax 2000;55:S51–S53.
5.
Rennard SI: Inflammation and repair processes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:S12–S16.
6.
Cantin AM, Hubbard RC, Crystal RG: Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1989;139:370–372.
7.
Buhl R, Jaffe HA, Holroyd KJ, Wells FB, Mastrangeli A, Saltini C, et al: Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989;ii:1294–1298.
8.
Beier J, Beeh KM, Kornmann O, Buhl R: Glutathione (GSH) measurement in induced sputum: Validity, stability and reproducibility. Am J Respir Crit Care Med 2002;165:A345.
9.
Kips J, Fahy JV, Hargreave F, Ind PW, in’t Veen JC: Methods for sputum induction and analysis of induced sputum: A method for assessing airway inflammation in asthma. Eur Respir J 1998;26:9s–12s.
10.
Bettschart RW, El-Kushman H, Spanevello A, Myers JD, Shakur H, Ind PW: Effect of storage on differential cell counts in induced sputum from COPD patients, smokers and normal subjects. Am J Respir Crit Care Med 1998;157:A812.
11.
Holz O, Mücke P, Zarza P, Loppow D, Jörres R, Magnussen H: Freezing of homogenized sputum samples for intermittent storage. Clin Exp Allergy 2001;31:1328–1331.
12.
Pizzichini E, Pizzichini MMM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al: Indices of airway inflammation in induced sputum: Reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308–317.
13.
Chinn S: Repeatability and method comparison. Thorax 1991;46:454–456.
14.
Bland JM, Altman DC: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307–310.
15.
Barton AD, Lourenco RV: Concerning the source and distribution of gamma-glutamyl-transpeptidase in sputum. J Lab Clin Med 1971;78:1004–1005.
16.
Lavoie JC, Chessex P: Development of glutathione synthesis and gamma-glutamyltranspeptidase activities in tissue from newborn infants. Free Radic Biol Med 1998;24:994–1001.
17.
Holz O, Richter K, Joerres RA, Speckin P, Muecke M, Magnussen H: Changes in sputum composition between two inductions performed on consecutive days. Thorax 1998;53:83–86.
18.
Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniack RM, Chinchilli VM, et al: Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001;163:1470–1475.
19.
Spanevello A, Migliori GB, Sharara A, Ballardini L, Bridge P, Pisati P, et al: Induced sputum to assess airway inflammation: A study of reproducibility. Clin Exp Allergy 1997;27:1138–1144.
20.
Brightling CE, Monterio W, Green RH, Parker D, Morgan MD, Wardlaw AJ, et al: Induced sputum and other outcome measures in chronic obstructive pulmonary disease: Safety and repeatability. Respir Med 2001;95:1999–2002.
21.
Holz O, Mucke M, Zarza P, Loppow D, Joerres RA, Magnussen H: Freezing of homogenized sputum samples for intermittent storage. Clin Exp Allergy 2001;31:1328–1331.
22.
Popov T, Baleva M, Shenkade M, Boyanowski B: Changes in the cellular and fluid phase components of sputum in the specific Antarctic environment. Eur Respir J 1998;12:438s.
23.
Kelly FJ, Mudway I, Blomberg A, Frew A, Sandstrom T: Altered lung antioxidant status in patients with mild asthma. Lancet 1999;354:482–483.
24.
Diegel H, Dauletbaev N, Viel K, Buhl R, Wagner TOF, Bargon J: Acid-treatment of BAL supernatant does not prevent the loss of glutathione during storage at –80°C. Am J Respir Crit Care Med 2000;161:A868.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.